Literature DB >> 26940152

Neuroinflammation in Synucleinopathies.

Somin Lim1, Yewon Chun1, Jun Sung Lee1, Seung-Jae Lee1.   

Abstract

The causes of most neurodegenerative diseases are attributed to multiple genetic and environmental factors interacting with one another. Above all, inflammation in the nervous system has been implicated in many neurodegenerative diseases. Still, the roles of neuroinflammation in disease mechanisms and the triggers of inflammatory responses in disease-inflicted brain tissues seem to remain unclear. This review will examine previous studies that had been done from genetic, pathological and epidemiological perspectives. These studies assess the involvement of neuroinflammation in synucleinopathies, a group of neurodegenerative diseases that are characterized by deposition of α-synuclein aggregates such as Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. The review will also discuss the role of α-synuclein aggregates in triggering inflammatory responses from glial cells. It is expected that a precise assessment of the roles and mechanisms of neuroinflammation in neurodegenerative diseases will pave the way for the development of disease-modifying drugs.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  Parkinson's disease; eurodegeneration; inflammation; microglia; synuclein

Mesh:

Substances:

Year:  2016        PMID: 26940152     DOI: 10.1111/bpa.12371

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  24 in total

1.  Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.

Authors:  Zachary A Sorrentino; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Kevin H Strang; Jason Caldwell; Benoit I Giasson
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

2.  Motor neuron loss and neuroinflammation in a model of α-synuclein-induced neurodegeneration.

Authors:  Zachary A Sorrentino; Yuxing Xia; Cory Funk; Cara J Riffe; Nicola J Rutherford; Carolina Ceballos Diaz; Amanda N Sacino; Nathan D Price; Todd E Golde; Benoit I Giasson; Paramita Chakrabarty
Journal:  Neurobiol Dis       Date:  2018-09-06       Impact factor: 5.996

Review 3.  The emerging role of α-synuclein truncation in aggregation and disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

4.  Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.

Authors:  Madelyn C Houser; Jianjun Chang; Stewart A Factor; Eric S Molho; Cyrus P Zabetian; Erin M Hill-Burns; Haydeh Payami; Vicki S Hertzberg; Malú G Tansey
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

5.  [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson's disease and healthy volunteers.

Authors:  Donatienne Van Weehaeghe; Michel Koole; Mark E Schmidt; Stephanie Deman; Andreas H Jacobs; Erika Souche; Kim Serdons; Stefan Sunaert; Guy Bormans; Wim Vandenberghe; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-26       Impact factor: 9.236

6.  Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease.

Authors:  Ashley S Harms; Aaron D Thome; Zhaoqi Yan; Aubrey M Schonhoff; Gregory P Williams; Xinru Li; Yudong Liu; Hongwei Qin; Etty N Benveniste; David G Standaert
Journal:  Exp Neurol       Date:  2017-11-16       Impact factor: 5.330

Review 7.  Prying into the Prion Hypothesis for Parkinson's Disease.

Authors:  Patrik Brundin; Ronald Melki
Journal:  J Neurosci       Date:  2017-10-11       Impact factor: 6.167

8.  Natural Compound from Olive Oil Inhibits S100A9 Amyloid Formation and Cytotoxicity: Implications for Preventing Alzheimer's Disease.

Authors:  Manuela Leri; Himanshu Chaudhary; Igor A Iashchishyn; Jonathan Pansieri; Željko M Svedružić; Silvia Gómez Alcalde; Greta Musteikyte; Vytautas Smirnovas; Massimo Stefani; Monica Bucciantini; Ludmilla A Morozova-Roche
Journal:  ACS Chem Neurosci       Date:  2021-05-12       Impact factor: 4.418

9.  α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.

Authors:  Benjamin Ettle; Kristina Kuhbandner; Stefanie Jörg; Alana Hoffmann; Jürgen Winkler; Ralf A Linker
Journal:  J Neuroinflammation       Date:  2016-08-26       Impact factor: 8.322

10.  Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.

Authors:  Concepción García; María Gómez-Cañas; Sonia Burgaz; Belén Palomares; Yolanda Gómez-Gálvez; Cristina Palomo-Garo; Sara Campo; Joel Ferrer-Hernández; Carolina Pavicic; Carmen Navarrete; M Luz Bellido; Moisés García-Arencibia; M Ruth Pazos; Eduardo Muñoz; Javier Fernández-Ruiz
Journal:  J Neuroinflammation       Date:  2018-01-16       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.